According to the latest visiongain report "Orphan Drugs: Future Directions for a High Growth Market 2004-2009", in 1983 there were just 10 orphan drugs available to treat rare diseases. However in the space of 20 years there are now 210 different drugs resulting in a market that is worth more than $27 billion today. The high cost of orphan drugs and lack of competition in the market means that the industry is extremely profitable for many drugs. - December 03, 2004

Attend visiongain's b2b conference, WIRELESS SPORT: EXPLORING FUTURE BRANDING AND REVENUE-GENERATING OPPORTUNITIES WITH SPORT IN WIRELESS, a unique conference where the mobile industry and the sports world meet to discuss content and branding partnerships. Key representatives from the sports world and mobile industry will gather at this unique venue at Chelsea Village, home ground of the Chelsea Football team. - November 16, 2004

According to the latest visiongain report "Blockbuster Drugs: A Current Assessment and Outlook for Creating Future Blockbusters", A blockbuster drug is defined as a medicine that generates more than $1 billion (U.S.) in sales in a year.
- November 15, 2004

According to the latest visiongain report "easymobile - Launching a competitive 'no frills' mobile brand", Since 1995, the easyGroup of companies has become synonymous with offering cut-price services and products through innovative business models. Will the company be able to take the success of their 'no frills' easyJet airline, to the mobile market? The easy brand has set it sights on gaining customers by becoming a slimmed down Mobile Virtual Network Operator (MVNO) service in partnership with Danish operator TDC. - November 01, 2004

According to the latest visiongain report " The Cardiovascular Report - 3rd Annual Edition", Cardiovascular is the leading therapeutic category in the pharmaceutical industry worldwide and with new drugs in the pipeline, competition in the cardiovascular market has never been greater. - November 01, 2004